Navigation Links
WebMD Health Corp. Announces Intention To Commence Tender Offer To Repurchase Up To 5,700,000 Shares of its Common Stock
Date:11/3/2009

NEW YORK, Nov. 3 /PRNewswire-FirstCall/ -- WebMD Health Corp. (Nasdaq: WBMD) announced today that it intends to commence a tender offer next week to purchase up to 5,700,000 shares of its common stock at a price per share of $36.00. The last reported sales price per share of WebMD's common stock on the Nasdaq Global Select Market on November 3, 2009 was $34.26 per share. The number of shares proposed to be purchased in the tender offer represents approximately 10% of WebMD's currently outstanding common shares.

Following the merger of HLTH Corporation into WebMD, completed on October 23, 2009, WebMD has approximately $1 billion in cash and investments. WebMD will use a portion of its cash and investments to fund the tender offer. The Board of Directors of WebMD, after evaluating expected capital requirements of WebMD's operations and other expected cash commitments, as well as the additional shares of WebMD common stock potentially issuable upon conversion of WebMD's 1.75% Convertible Notes, believes that purchasing shares of WebMD's common stock in the tender offer represents a superior alternative to other available uses of the funds required for the tender offer.

None of WebMD, its Board of Directors, or the information agent for the tender offer will make any recommendations to stockholders as to whether to tender or refrain from tendering their shares into the tender offer. Stockholders must decide how many shares they will tender, if any.

THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF WEBMD HEALTH CORP. COMMON STOCK. THE TENDER OFFER WILL BE MADE ONLY PURSUANT TO AN OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT WEBMD INTENDS TO DISTRIBUTE TO ITS STOCKHOLDERS AND FILE WITH THE SECURITI
'/>"/>

SOURCE WebMD
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. WebMD Launches New Consumer Health Portal in the U.K.
2. WebMD and HLTH Corporation to Webcast Annual Meetings of Stockholders
3. Solos Endoscopy, Inc. Receives Purchase Orders from Catholic Health Initiatives for its MammoView(TM) Product Line
4. Gentiva(R) Health Services to Present at the Credit Suisse Healthcare Conference
5. Quest Diagnostics To Speak At The Oppenheimer 20th Annual Healthcare Conference
6. DCED Helping PA Companies Do Business in Growing United Arab Emirates Market for Health Care Products, Services
7. Arcadia Resources to Present at Lazard Healthcare Conference in New York
8. HealthSouth to Present at 6th Annual Lazard Healthcare Conference
9. Inappropriate Initial Antibiotic Treatment May Extend Stays for Patients with Healthcare-Associated Skin Infections
10. Bayer HealthCare Presents Florbetaben Phase II Study Results at World Congress of Neurology
11. NuVasive to Present at the Oppenheimer 20th Annual Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009).... 25 /PRNewswire-Asia-FirstCall/ -- China Sky One,...pany") (Nasdaq: CSKI ), a,leading fully integrate...over-the-counter drugs in the People,s Republic of...ecently passed the Chinese National Institute for,...cts ("ICPBP") examination,for two of its new produ...
(Date:11/25/2009)...Newswire/ -- Reportlinker.com announces that a new...gue: ,, Mammography Equipment - A Global Mark...m/p0164330/Mammography-Equipment---A-Global-Market...t cancer in industrialized as well as developing n... the mammography market. Globally, escalating awar...
(Date:11/25/2009)...v. 25 Swissray International, Inc....phy ( ddR ) systems, announced today that its oper...tor with a long term view towards growing Swissray... all assets and intellectual property, as well as ... and growth Swissray is now poised to move to the ...
Breaking Medicine Technology:China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 2China Sky One Medical, Inc. Achieved Progress in the Development of Two New Biological Testing Kits 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8Swissray International Announces New Ownership 2AMD LASERS Announces New Partnership with Dr Larry Rosenthal and Aesthetic Advantage 6460 1AMD LASERS Announces New Partnership with Dr Larry Rosenthal and Aesthetic Advantage 6460 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 1Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 6458 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 1Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 5Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 6Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 7Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 8Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 9Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 6455 10
(Date:11/27/2009)...7 Shamir Optical Industr...ovider of innovative products and technology to th... board of directors had declared a dividend distri...pproximately NIS 37.62 million based on the Novemb...pproximately US$ 0.609 (approximately NIS 2.3 base...
(Date:11/27/2009)...rade; announced today that Spectrum Health (Grand ...prise orthopedic templating solution and its Traum... (PRWEB) November 27, 2009 -- Voyant Health...d Rapids, Michigan) has licensed its TraumaCad Ent...umaCad Extend workflow solution, to allow its orth...
(Date:11/26/2009)...RNewswire/ -- The diabetes population in the Unite... and annual medical spending on the disease is pro...oday, according to a study published in the Decemb...ng Diabetes ® Program (NCDP), a program of No...om the University of Chicago. ,, According to t...
(Date:11/26/2009)... from the North Pole, Textsanta.net lets parents s..., North Pole, AK (PRWEB) -...s at the North Pole Santa Claus has added SMS text...e informed of his Christmas progress at the North ...nt have identified a large and growing percentage ...
(Date:11/25/2009)...wire-USNewswire/ -- When most people hear the acro...practor can also give patients the help they need....ch is where your jaw (mandible) contacts/connects ...ommon symptoms associated with TMJ dysfunction are.... But many other symptoms can be caused from TMJ ...
Breaking Medicine News(10 mins):Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 2Health News:Shamir Optical Industry Ltd. Announces Declaration of a Cash Dividend 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 2Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 3Health News:Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows 4Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2
...inois have found that a molecular pathway known to...humans is also critical to the pathology// of skel...d to advances in the palliative care of companion ...e of an enzyme, receptor activator of nuclear fact...
... not linked to a cluster of cases in Clendon, Sout...been treated for typhoid in Porirua and those case...edical officer of health, regional public health, ... the cases were in late January and one was early ...
...ies is expected to aid in longevity of life. This ...e Zutphen Study.// According to this study, a ...ular deaths and increase the life span in middle a...n body. This research studied the pattern of a...
... of losing weight. Belgium’s Janssen Animal Health...gs shed the flab.// The drug works by blocking...eat into their bloodstream. It does not affect t...y to beg for its favorite snack. Studies acros...
...nted by Finance minister P.Chidambaram has drawn c...his introductory remarks he// said: 'The education...funds. In 2007-08, I propose to enhance the alloca...ng has been a high priority and smokers have alway...
...ssue of the journal SLEEP finds that people with o... for cardiovascular disease.// The study att...ascular disease to heightened recognition and a ri... "There is abundant physiologic evidence imp...
Other Medicine News:Health News:Insights into Osteosarcoma in Cats and Dogs may Improve Palliative Care 2Health News:Union Budget: Impact on Health Sector 2Health News:Union Budget: Impact on Health Sector 3Health News:Sleep Well, Have a Healthy Heart ! 2
The Closer
5.2F Supertorque Plus
Torcon NB Advantage
8F Standard
Medicine Products: